Education
About Us
Working with TipRanks
Follow Us
Alpha Teknova, Inc. (TKNO)
:TKNO
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.13Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -15.38%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with both positive and negative elements. While the company showed growth in overall revenue and improved gross margins, specific segments such as custom products and clinical solutions faced challenges. Additionally, uncertainties in the biotech funding environment could impact future performance. However, strategic collaborations and a reduction in net losses were positive indicators.Company Guidance
During Alpha Teknova's first quarter 2025 earnings call, the company reported a 5% increase in total revenue to $9.8 million compared to the same quarter in 2024. CEO Stephen Gunstream highlighted the company's diverse customer base and limited geopolitical exposure, with less than 5% of revenue from international sales and minimal impact expected from tariff changes. The company maintained its full-year revenue guidance of $39 million to $42 million, anticipating growth rates of mid-single digits for catalog products, at least 15% for biopharma products, and mid-single digits for custom life science tools and diagnostics. Notable financial metrics from CFO Matt Lowell included a gross margin increase to 30.7% from 23.8% the previous year and a net loss reduction to $4.6 million from $8.1 million. Teknova also discussed strategic initiatives, including a collaboration with Pluristics to expand its product portfolio, aiming for sustainable long-term growth with an expected annual growth rate of 20-25%.Revenue Growth
Revenue increased by 5% in Q1 2025 compared to Q1 2024, reaching $9.8 million. LabEssentials revenue rose by 12% year-over-year.
Gross Margin Improvement
Gross margin improved to 30.7% in Q1 2025, up from 23.8% in Q1 2024, driven by higher revenue and lower overhead costs.
Custom Biopharma Segment Growth
The number of clinical customer accounts purchasing more than $5,000 annually increased from 13 in 2020 to 48 in 2024, with expected mid-teens growth in Q1 2025.
Collaboration with Pluristics
Signed a collaboration agreement with Pluristics for exclusive manufacturing and distribution of the Flurry Freeze product line in the US and Canada.
Decrease in Net Loss
Net loss reduced to $4.6 million in Q1 2025 from $8.1 million in Q1 2024, with adjusted EBITDA improving to negative $2.5 million from negative $3.8 million.
TKNO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TKNO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $6.37 | $6.96 | +9.26% |
Mar 04, 2025 | $6.04 | $5.97 | -1.16% |
Nov 07, 2024 | $6.89 | $7.16 | +3.92% |
Aug 13, 2024 | $3.97 | $3.71 | -6.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Alpha Teknova, Inc. (TKNO) report earnings?
Alpha Teknova, Inc. (TKNO) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Alpha Teknova, Inc. (TKNO) earnings time?
Alpha Teknova, Inc. (TKNO) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TKNO EPS forecast?
TKNO EPS forecast for the fiscal quarter 2025 (Q2) is -0.1.